Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meckbach

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Health Physics|January 12, 2008
Credibility of Chernobyl thyroid doses exceeding 10 Gy based on in-vivo measurements of 131I in BelarusSergey M Shinkarev, Paul G Voillequé, Yury I Gavrilin, et al.
British Journal of Cancer|April 13, 2013
Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practiceL Heinzerling, S Kühnapfel, D Meckbach, et al.
Endoscopy|December 17, 2013
Capnographic monitoring of propofol-based sedation during colonoscopyMireen Friedrich-Rust, Maria Welte, Carmen Welte, et al.
Radiation Research|January 6, 2006
Thyroid cancer risk in areas of Ukraine and Belarus affected by the Chernobyl accidentP Jacob, T I Bogdanova, E Buglova, et al.
Plos One|January 30, 2014
Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanomaDiana Meckbach, Jürgen Bauer, Annette Pflugfelder, et al.
Health Physics|August 13, 2005
Retrospective luminescence dosimetry: development of approaches to application in populated areas downwind of the Chernobyl NPPI K Bailiff, V F Stepanenko, H Y Göksu, et al.
Health Physics|December 26, 2003
Comparison of retrospective luminescence dosimetry with computational modeling in two highly contaminated settlements downwind of the Chernobyl NPPI K Bailiff, V F Stepanenko, H Y Göksu, et al.
Pigment Cell & Melanoma Research|April 8, 2014
In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survivalMoritz Menzel, Diana Meckbach, Benjamin Weide, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Health Physics|January 12, 2008
Credibility of Chernobyl thyroid doses exceeding 10 Gy based on in-vivo measurements of 131I in BelarusSergey M Shinkarev, Paul G Voillequé, Yury I Gavrilin, et al.
British Journal of Cancer|April 13, 2013
Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practiceL Heinzerling, S Kühnapfel, D Meckbach, et al.
Endoscopy|December 17, 2013
Capnographic monitoring of propofol-based sedation during colonoscopyMireen Friedrich-Rust, Maria Welte, Carmen Welte, et al.
Radiation Research|January 6, 2006
Thyroid cancer risk in areas of Ukraine and Belarus affected by the Chernobyl accidentP Jacob, T I Bogdanova, E Buglova, et al.
Plos One|January 30, 2014
Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanomaDiana Meckbach, Jürgen Bauer, Annette Pflugfelder, et al.
Health Physics|August 13, 2005
Retrospective luminescence dosimetry: development of approaches to application in populated areas downwind of the Chernobyl NPPI K Bailiff, V F Stepanenko, H Y Göksu, et al.
Health Physics|December 26, 2003
Comparison of retrospective luminescence dosimetry with computational modeling in two highly contaminated settlements downwind of the Chernobyl NPPI K Bailiff, V F Stepanenko, H Y Göksu, et al.
Pigment Cell & Melanoma Research|April 8, 2014
In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survivalMoritz Menzel, Diana Meckbach, Benjamin Weide, et al.
Pageof 6